RESUMEN
BACKGROUND: Many COVID-19 survivors suffer from post-COVID syndrome, which significantly worsens the quality of life. Its presentation is quite diverse, with cognitive disorders being of particular importance. Liver injury due to the direct virus action and the treatment of the new coronavirus infection can persist for a long time during the recovery period and lead to hyperammonemia, which can cause cognitive disorders, including minimal hepatic encephalopathy. AIM: To study cognitive disorders in post-COVID syndrome and the possibility of their treatment with L-ornithine-L-aspartate. MATERIALS AND METHODS: The study included 30 students from 18 to 24 years old who had COVID-19 and decreased attention, memory impairment, and other cognitive disorders inherent in hepatic encephalopathy of latent (grade 0) or mild (grade 1) severity, without pronounced impairment of intelligence, memory, speech, and learning ability. Hyperammonemia, elevated alanine aminotransferase, aspartate aminotransferase, and ã-glutamyl transpeptidase, signs of hepatic encephalopathy according to psychometric tests, were reported in young people. All patients in the study were treated with L-ornithine-L-aspartate to correct the ammonia blood level and improve signs of hepatic encephalopathy and the general condition. RESULTS AND CONCLUSION: An improvement in the objective findings, liver enzymes, a decrease in ammonia level, and an improvement in testing results for changes in cognitive functions were reported.
Asunto(s)
COVID-19 , Encefalopatía Hepática , Hiperamonemia , Humanos , Adolescente , Adulto Joven , Adulto , Encefalopatía Hepática/etiología , Amoníaco , Calidad de Vida , COVID-19/complicacionesRESUMEN
The purpose of the study was to compare the effectiveness of various compression techniques with a prolonged-action patch on postoperative scars. MATERIAL AND METHODS: The study included 21 patients aged 3.6±1.7 years who had scars after surgery. The patients were divided into two groups: group No 1 (n=11), in which they applied longitudinal patch of prolonged-action Contractubex according to the standard technique; group No 2 (n=10) - transverse imposition of the patch on the postoperative scar (according to the author's method). RESULTS: In 20 (95.5%) patients, good compliance was noted. By the 90th day after surgery, the width of the scar in the group No. 1 was significantly larger than in the group No. 2, being 2.5±0.15 and 2.0±0.1 (p<0.05). CONCLUSION: Thus, the effectiveness of the proposed technique of transverse imposition of the patch Contractubex on the postoperative scar after surgical intervention was confirmed by a good cosmetic and functional result of scar formation.
Asunto(s)
Cicatriz/terapia , Vendajes de Compresión , Preescolar , Cicatriz/etiología , Humanos , Lactante , Herida Quirúrgica/complicacionesRESUMEN
The aim of the study was to evaluate the effectiveness of compression therapy with a prolonged plaster of Contractubex in the formation of skin scarring in children after surgery. MATERIAL AND METHODS: In a prospective open-label randomized trial, 109 patients aged 5.3±2.1 years after surgery: boys - 73, girls - 36. Patients were divided into 2 groups: in the main group (54 children) the application of the prolonged plaster Contractubex was performed; in the control group (55 patients) - dynamic observation. The scar deformation was assessed according to the Vancouver scale for 10, 30 and 90 postoperative days. RESULTS: 94.4% patients had good compliance; in 2 (3.7%) - satisfactory; in 1 (1.9%) - unsatisfactory compliance. In our study, the formation of hypertrophic scars in the main group was significantly less frequent than in the control group (1 and 8 patients, respectively, χ2=4.241, p=0.042). CONCLUSION: Thus, the use of the prolonged plaster Contractubex in the near and distant period a good cosmetic and functional result in the formation of a postoperative scar was provided.